Navigation Links
Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc.
Date:11/21/2008

Special meeting of shareholders to be held on January 8, 2009

TORONTO, Nov. 21 /PRNewswire-FirstCall/ - Med-Emerg International Inc. ("MedEmerg") (OTCBB: MDER), one of Canada's leading providers of health services, announced today that it has obtained an interim order from the Ontario Superior Court of Justice concerning its previously announced plan of arrangement (the "Arrangement") pursuant to which AIM Health Group Inc. ("AIM") will acquire all of MedEmerg's outstanding shares. Under the Arrangement, holders of MedEmerg common shares will receive 0.78091 of an AIM common share for each MedEmerg common share, subject to adjustment in the case of fractional AIM common shares and Calian Technologies Ltd., the sole holder of Special Shares, Series 1 of MedEmerg, will exchange all of such shares for a secured convertible debenture of AIM. In addition, MedEmerg options will be exchanged for AIM options and MedEmerg warrants will be cancelled.

A special meeting of shareholders, called to approve the Arrangement, will be held on January 8, 2009. Shareholders of record on November 24, 2008 will be entitled to receive notice and vote at the special meeting. MedEmerg will mail a management information circular and related meeting materials to shareholders in connection with the special meeting next week. These documents will be filed under MedEmerg's company profile on SEDAR at www.sedar.com.

The Board of Directors of MedEmerg has recommended that MedEmerg shareholders vote in favour of the Arrangement.

About Med-Emerg International Inc.

MedEmerg specializes in the coordination and delivery of health care services in Canada. These services include an integrated chronic pain management program, community-based infusion centers and health human resource management, including physician and nurse staffing.

Med-Emerg's audited revenue for its fiscal year ended December 31, 2007 was approximately US$22 million.

(www.medemerg.com)

Caution Concerning Forward-Looking Statements

Certain statements in this press release are forward-looking statements, including, but not limited to, the timing of the special meeting of shareholders and other statements that are not historical facts. These statements are based upon certain material factors, assumptions and analyses that were applied in drawing a conclusion or making a forecast or projection, including MedEmerg's experience and perceptions of historical trends, current conditions and expected future developments, as well as other factors that are believed to be appropriate in the circumstances. Forward-looking statements are provided for the purpose of presenting information about management's current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. Forward-looking statements include statements that are predictive in nature, depend upon or refer to future events or conditions, or include words such as "expects", "anticipates", "plans", "believes", "estimates", "intends", "targets", "projects", "forecasts", "seeks", "likely" or negative versions thereof and other similar expressions, or future or conditional verbs such as "may", "will", "should", "would" and "could".

By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusion will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of material factors, many of which are beyond MedEmerg's control, affect operations, performance, achievements and results of MedEmerg that may be expressed or implied by such forward-looking statements and could cause actual results to differ materially from current expectations of estimated or anticipated events or results.

These forward-looking statements are made as of the date of this release and, other than as specifically required by law, MedEmerg assumes no obligation to update or revise any forward-looking statement to reflect events or circumstances after the date on which such statement is made, or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.

Additional information about the risks and uncertainties of MedEmerg's business is provided in its disclosure materials filed with the securities regulatory authorities in Canada, available at www.sedar.com.


'/>"/>
SOURCE Med-Emerg International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Med-Emerg International Inc. reports improved income from continuing operations
2. Permanent International Healthcare Marketplace and Education Center Set to Open in New York City in 2013
3. Epocrates Offers International Market Research Panel
4. Accreditation to the International Standards Organization for Quality Management Granted to First U.S. Lab
5. MINRAD International, Inc. to Discuss Current Business Conditions on Tuesday, November 25, 2008
6. Lilly and International Council of Nurses Win Partnership Award From the U.S. Chamber of Commerce Business Civic Leadership Center
7. UIC joins international research effort to study autism
8. Service Corporation International Increases Share Repurchase Authorization to $150 Million and Declares Quarterly Cash Dividend
9. AACR to host 7th Annual International Conference on Frontiers in Cancer Prevention Research
10. Anthem Blue Cross and Blue Shield Introduces International Medical Tourism Pilot Program
11. Lilly Announces Major Donation of Insulin to International Diabetes Federations Life for a Child Program; Initial Focus Will Be on Sub-Saharan Africa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2017)... ... June 26, 2017 , ... LARKR™ , an innovative new smartphone app ... across the country to join its online treatment platform. , Launching in just ... a substantially greater number of people in need nationwide, and to supplement their traditional ...
(Date:6/26/2017)... ... June 26, 2017 , ... New patients with missing teeth ... with or without a referral. Dr. Cotey is a trusted dentist who has placed ... replacement option. , Patients with missing teeth in Fitchburg, WI, are encouraged to find ...
(Date:6/25/2017)... , ... June 25, 2017 , ... Republicans in the ... and replace Obamacare, called the Better Care Reconciliation Act. It differs significantly from the ... will need to be reconciled in committee, or the House will have to take ...
(Date:6/25/2017)... ... ... heatwave currently bearing down on Northern California pushing temperatures to the maximum, many people are ... with laser hair removal. , The process of summer waxing and constantly shaving unwanted ... want to do is get out, dive in and cool off. There is a way ...
(Date:6/24/2017)... ... June 24, 2017 , ... ... PA at the Sheraton Erie Bayfront and Erie Convention Center on June 8-10. ... experience, exhibits, a student quiz bowl, award and scholarship presentations, and professional networking. ...
Breaking Medicine News(10 mins):
(Date:5/30/2017)... CAESAREA, Israel , May 30, 2017 DarioHealth Corp. ... and big data solutions, today announced that it will be presenting ... 2017, at 8:00 AM PT. Erez Raphael , CEO, of ... The conference will be held on June 6th & 7th, ... 180 companies in the small / micro-cap space. ...
(Date:5/26/2017)... plc (NASDAQ: ENDP ) announced today that ... in a fireside chat at Goldman Sachs, 38 th ... 10:40 a.m. PT / 1:40 p.m. ET. The conference will ... Verdes, CA. A live webcast and ... Company,s website at http://www.endo.com/investors/overview . Participants should allow approximately ...
(Date:5/22/2017)... , May 22, 2017  Lilac Corp, ... Gene-Eden-VIR/Novirin, announces the launch of a new ... the results of a clinical study that showed ... treatment with Gene-Eden-VIR/Novirin in individuals suffering from HPV ... note that there are no other treatments that ...
Breaking Medicine Technology: